![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 28, 2006
Medicine and Physiology and Biophysics, University of Illinois at Chicago and Jesse Brown VA Medical Center, Chicago, Illinois 60612
Corresponding Author: unterman{at}uic.edu
FoxO transcription factors are important targets of insulin action. To better understand the role of FoxO proteins in the liver, we created transgenic mice expressing constitutively active FoxO1 in the liver using the
J. Biol. Chem, 10.1074/jbc.M600272200
Submitted on January 10, 2006
Revised on February 14, 2006
Accepted on February 21, 2006
FOXO1 regulates multiple metabolic pathways in the liver: Effects on gluoconeogenic, glycolytic and lipogenic gene expression
1-antitrypsin promoter. Fasting blood glucose levels are increased despite high insulin levels, and glucose tolerance is impaired in transgenic (TGN) vs. wild type (WT) mice. Interestingly, fasting triglyceride and cholesterol levels are reduced despite hyperinsulinemia, and post-prandial changes in triglyceride levels are markedly suppressed in TGN vs. WT mice. Activation of pro-lipogenic signaling pathways (atypical protein kinase C, protein kinase B) and the ability to suppress beta-hydroxybutyrate levels are not impaired in TGN. In contrast, de novo lipogenesis measured with 3H2O is suppressed by ~70% in the liver of TGN vs. WT mice after refeeding. Gene array studies reveal that the expression of genes involved in gluconeogenesis, glycerol transport and amino acid catabolism is increased, while expression of genes involved in glucose utilization by glycolysis, the pentose phosphate shunt, and lipogenic and sterol synthetic pathways is suppressed in TGN vs. WT. Studies in isolated hepatocytes confirm that FoxO1 stimulates expression gluconeogenic genes and suppresses expression of genes involved in glycolysis, the pentose phosphate shunt and lipogenesis, including glucokinase and SREBP-1c. These results indicate that FoxO proteins promote hepatic glucose production through multiple mechanisms, and also contribute to the regulation of other metabolic pathways important in the adaptation to fasting and feeding in the liver, including glycolysis, the pentose phosphate shunt, and lipogenic and sterol synthetic pathways.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Chahal, C.-C. Chen, M. J. Rane, J. P. Moore, M. T. Barati, Y. Song, and B. C. Villafuerte Regulation of Insulin-Response Element Binding Protein-1 in Obesity and Diabetes: Potential Role in Impaired Insulin-Induced Gene Transcription Endocrinology, October 1, 2008; 149(10): 4829 - 4836. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Satapati, T. He, T. Inagaki, M. Potthoff, M. E. Merritt, V. Esser, D. J. Mangelsdorf, S. A. Kliewer, J. D. Browning, and S. C. Burgess Partial Resistance to Peroxisome Proliferator-Activated Receptor-{alpha} Agonists in ZDF Rats Is Associated With Defective Hepatic Mitochondrial Metabolism Diabetes, August 1, 2008; 57(8): 2012 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Housley, J. T. Rodgers, N. D. Udeshi, T. J. Kelly, J. Shabanowitz, D. F. Hunt, P. Puigserver, and G. W. Hart O-GlcNAc Regulates FoxO Activation in Response to Glucose J. Biol. Chem., June 13, 2008; 283(24): 16283 - 16292. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Nahle, M. Hsieh, T. Pietka, C. T. Coburn, P. A. Grimaldi, M. Q. Zhang, D. Das, and N. A. Abumrad CD36-dependent Regulation of Muscle FoxO1 and PDK4 in the PPAR{delta}/{beta}-mediated Adaptation to Metabolic Stress J. Biol. Chem., May 23, 2008; 283(21): 14317 - 14326. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kamei, S. Miura, T. Suganami, F. Akaike, S. Kanai, S. Sugita, A. Katsumata, H. Aburatani, T. G. Unterman, O. Ezaki, et al. Regulation of SREBP1c Gene Expression in Skeletal Muscle: Role of Retinoid X Receptor/Liver X Receptor and Forkhead-O1 Transcription Factor Endocrinology, May 1, 2008; 149(5): 2293 - 2305. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Martinez, K. Tanabe, C. Cras-Meneur, N. A. Abumrad, E. Bernal-Mizrachi, and M. A. Permutt Inhibition of Foxo1 Protects Pancreatic Islet {beta}-Cells Against Fatty Acid and Endoplasmic Reticulum Stress-Induced Apoptosis Diabetes, April 1, 2008; 57(4): 846 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yan, V. A. Lavin, L. R. Moser, Q. Cui, C. Kanies, and E. Yang PP2A Regulates the Pro-apoptotic Activity of FOXO1 J. Biol. Chem., March 21, 2008; 283(12): 7411 - 7420. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. G. Ni, N. Wang, D. J. Cao, N. Sachan, D. J. Morris, R. D. Gerard, M. Kuro-o, B. A. Rothermel, and J. A. Hill FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases PNAS, December 18, 2007; 104(51): 20517 - 20522. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Southgate, B. Neill, O. Prelovsek, A. El-Osta, Y. Kamei, S. Miura, O. Ezaki, T. J. McLoughlin, W. Zhang, T. G. Unterman, et al. FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle J. Biol. Chem., July 20, 2007; 282(29): 21176 - 21186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ono, D. J. Chia, R. Merino-Martinez, A. Flores-Morales, T. G. Unterman, and P. Rotwein Signal Transducer and Activator of Transcription (Stat) 5b-Mediated Inhibition of Insulin-Like Growth Factor Binding Protein-1 Gene Transcription: A Mechanism for Repression of Gene Expression by Growth Hormone Mol. Endocrinol., June 1, 2007; 21(6): 1443 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshida, K. Murao, H. Imachi, W. M. Cao, X. Yu, J. Li, R. A. M. Ahmed, N. Kitanaka, N. C. W. Wong, T. G. Unterman, et al. Pancreatic Glucokinase Is Activated by Insulin-Like Growth Factor-I Endocrinology, June 1, 2007; 148(6): 2904 - 2913. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Naimi, N. Gautier, C. Chaussade, A. M. Valverde, D. Accili, and E. Van Obberghen Nuclear Forkhead Box O1 Controls and Integrates Key Signaling Pathways in Hepatocytes Endocrinology, May 1, 2007; 148(5): 2424 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Egea, I Meton, and I V Baanante Sp1 and Sp3 regulate glucokinase gene transcription in the liver of gilthead sea bream (Sparus aurata) J. Mol. Endocrinol., April 1, 2007; 38(4): 481 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gonzalez-Rodriguez, J. E. Clampit, O. Escribano, M. Benito, C. M. Rondinone, and A. M. Valverde Developmental Switch from Prolonged Insulin Action to Increased Insulin Sensitivity in Protein Tyrosine Phosphatase 1B-Deficient Hepatocytes Endocrinology, February 1, 2007; 148(2): 594 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buteau, A. Shlien, S. Foisy, and D. Accili Metabolic Diapause in Pancreatic beta-Cells Expressing a Gain-of-function Mutant of the Forkhead Protein Foxo1 J. Biol. Chem., January 5, 2007; 282(1): 287 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Qu, J. Altomonte, G. Perdomo, J. He, Y. Fan, A. Kamagate, M. Meseck, and H. H. Dong Aberrant Forkhead Box O1 Function Is Associated with Impaired Hepatic Metabolism Endocrinology, December 1, 2006; 147(12): 5641 - 5652. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Li, X. Kong, E. Owsley, E. Ellis, S. Strom, and J. Y. L. Chiang Insulin Regulation of Cholesterol 7{alpha}-Hydroxylase Expression in Human Hepatocytes: ROLES OF FORKHEAD BOX O1 AND STEROL REGULATORY ELEMENT-BINDING PROTEIN 1c J. Biol. Chem., September 29, 2006; 281(39): 28745 - 28754. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, D. Botolin, J. Xu, B. Christian, E. Mitchell, B. Jayaprakasam, M. Nair, J. M. Peters, J. Busik, L. K. Olson, et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity J. Lipid Res., September 1, 2006; 47(9): 2028 - 2041. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |